Prevention
Educational materials that cover preventative measures and harm reduction strategies to prevent the transmission of hepatitis C.
Materials in this section
Canada: Study Finds Federal Needle Exchange Programs Reduce Health Care Costs and Blood-Borne Infections
Researchers from Canada and Australia sought to assess the return on investment for Canada’s prison needle exchange programs, and the potential impact of scaling it up, as part of efforts to eliminate blood-borne infections in prisons. More
Rate of Hepatitis C Reinfection After Successful Treatment Among PWID in Spain
Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study More
Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain
A study assessed risk factors, prevalence, and trends of active HCV infection among people experiencing homelessness in Madrid, Spain (2019-2023). More
Trends in Viral Infections in Quebec Among People Who Inject Drugs
Researchers in Quebec have been surveying nearly 16,000 people who inject drugs; Between 1995 and 2020 they found decreases in HIV infections and sharing of drug equipment; However, rates of exposure to hepatitis C virus did not decrease as much. More
Moldova’s Progressive Prison Reforms Cut HIV Transmission to Zero
Unlike many European countries that have abandoned needle and syringe exchange programs for inmates, Moldova has continued to press ahead with innovative prison reforms aimed at reducing the spread of diseases like HIV and hepatitis B and C. More
HCV Prevalence and Phylogenetic Characteristics of Young People Who Inject Drugs in New York City
HCV prevalence and phylogenetic characteristics in a cross‐sectional, community study of young people who inject drugs in New York City: Opportunity for and threats to HCV elimination More
European Harm Reduction Services Adapt and Advance Amid COVID-19 Challenges
A study details the significant transformations in harm reduction services across Europe during the COVID-19 pandemic. More
Hepatitis C Reinfection Common Among Treated PWID
Among PWID treated for hepatitis C, rates of reinfection were high soon after sustained virologic response but decreased with longer follow-up, according to a secondary analysis of the randomized HERO trial. More
Update on Hepatitis C Vaccine: Results and Challenges
The development of an effective HCV vaccine remains a critical challenge due to the low number of patients treated with DAAs and the occurrence of HCV reinfections in high-risk groups. More
Prevalence of Hepatitis B and C Among HIV-Positive MSM
Prevalence of hepatitis B and C among HIV-positive men who have sex with men: A systematic review and meta-analysis More
